Wyndham H Wilson Selected Research

Wyndham H Wilson Research Topics

Disease

48	Neoplasms (Cancer) 05/2024 - 06/2002
39	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 06/2002
30	Lymphoma (Lymphomas) 04/2024 - 02/2002
15	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2021 - 09/2002
14	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021 - 02/2002
12	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 09/2005
8	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2024 - 06/2006
6	Neutropenia 05/2023 - 08/2005
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016 - 08/2005
5	Hairy Cell Leukemia 01/2018 - 11/2004
5	Disease Progression 05/2015 - 09/2004
4	Infections 05/2023 - 06/2009
4	Leukemia 01/2020 - 09/2009
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 08/2014 - 11/2004
4	Hemolytic-Uremic Syndrome 05/2012 - 09/2005
4	Acquired Immunodeficiency Syndrome (AIDS) 03/2012 - 06/2003
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2010 - 02/2006
3	Lymphopenia (Lymphocytopenia) 05/2023 - 12/2010
3	Thrombocytopenia (Thrombopenia) 01/2023 - 09/2002
3	Residual Neoplasm 01/2022 - 12/2021
3	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 08/2010
3	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 11/2014 - 04/2006
2	Aspergillosis 05/2024 - 12/2017
2	Febrile Neutropenia 01/2023 - 01/2021
2	Inflammation (Inflammations) 01/2020 - 01/2011
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2018 - 12/2010
2	Multiple Myeloma 10/2017 - 10/2010
2	Hematologic Neoplasms (Hematological Malignancy) 09/2014 - 06/2011
2	Hypoalbuminemia 05/2012 - 09/2005
2	Fatigue 05/2012 - 09/2005
2	Edema (Dropsy) 05/2012 - 09/2005
2	T-Cell Lymphoma (Lymphoma, T Cell) 02/2011 - 07/2007
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2010 - 02/2006
2	Pneumonia (Pneumonitis) 05/2010 - 12/2004
2	Opportunistic Infections (Opportunistic Infection) 04/2010 - 07/2006
1	Leukopenia 05/2023
1	Lymphomatoid Granulomatosis (Granulomatosis, Lymphomatoid) 05/2023
1	Anemia 01/2021
1	COVID-19 01/2020
1	Adenocarcinoma 01/2019

Drug/Important Bio-Agent (IBA)

28	Rituximab (Mabthera)FDA Link 01/2020 - 02/2002
17	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 02/2002
17	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 02/2002
17	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 02/2002
17	Prednisone (Sone)FDA LinkGeneric 01/2020 - 02/2002
16	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 02/2002
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2007
9	Circulating Tumor DNAIBA 11/2022 - 01/2016
7	ibrutinibIBA 12/2021 - 08/2015
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2005
6	Monoclonal AntibodiesIBA 01/2018 - 02/2002
6	Cyclin D1IBA 11/2013 - 02/2003
5	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 06/2002
5	fludarabineIBA 08/2013 - 09/2002
4	Agammaglobulinaemia Tyrosine KinaseIBA 05/2024 - 12/2017
4	Bortezomib (Velcade)FDA Link 09/2015 - 06/2009
4	Anaplastic Lymphoma KinaseIBA 08/2014 - 11/2004
4	Immunotoxins (Immunotoxin)IBA 05/2012 - 09/2005
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 10/2010
3	Lenalidomide (CC 5013)FDA Link 01/2021 - 09/2009
3	immunotoxin HA22IBA 01/2018 - 06/2011
3	Transaminases (Aminotransferases)IBA 05/2012 - 09/2005
3	Chimeric Antigen ReceptorsIBA 03/2012 - 09/2009
3	AntigensIBA 09/2009 - 09/2005
2	Indicators and Reagents (Reagents)IBA 01/2023 - 09/2011
2	AnthracyclinesIBA 01/2022 - 12/2010
2	navitoclaxIBA 01/2021 - 12/2010
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2019 - 03/2010
2	Alemtuzumab (Campath)FDA Link 01/2019 - 06/2004
2	AntibodiesIBA 01/2019 - 01/2011
2	Janus KinasesIBA 09/2014 - 02/2013
2	CytokinesIBA 03/2012 - 09/2009
2	NF-kappa B (NF-kB)IBA 01/2011 - 06/2006
2	Messenger RNA (mRNA)IBA 06/2007 - 02/2003
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 04/2024
1	GlucocorticoidsIBA 04/2024
1	src-Family KinasesIBA 04/2024
1	Interferon alpha-2 (Roferon-A)FDA Link 05/2023
1	BilirubinIBA 01/2023
1	Complement System Proteins (Complement)IBA 11/2022
1	Cell-Free Nucleic AcidsIBA 12/2021
1	Phospholipases (Phospholipase)IBA 11/2021
1	C-Reactive ProteinIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	acalabrutinibIBA 01/2020
1	alvocidib (flavopiridol)IBA 12/2019
1	Immunoglobulin Variable RegionIBA 01/2019
1	Cytidine DeaminaseIBA 01/2019

Therapy/Procedure

38	Therapeutics 11/2022 - 04/2002
29	Drug Therapy (Chemotherapy) 05/2023 - 02/2002
4	Precision Medicine 11/2022 - 01/2019
3	Highly Active Antiretroviral Therapy (HAART) 04/2012 - 06/2003
2	Radiotherapy 01/2018 - 04/2013
2	Hematopoietic Stem Cell Transplantation 03/2012 - 03/2003
2	Immunotherapy 03/2012 - 03/2008
2	Transplantation 03/2012 - 03/2003
2	Aftercare (After-Treatment) 04/2010 - 10/2005
2	Plasmapheresis 06/2009 - 09/2005
1	Artificial Respiration (Mechanical Ventilation) 01/2020